|
|
 |
|
Irvine, Calif. – August 8, 2008 – Relsys International released Service Pack 2 (SP2) of the Argus Safety™ 4.2 Suite, further augmenting the most widely licensed drug safety database in the world. This is a full suite upgrade, including enhancements to most modules of the Argus Suite.
Advanced new features support the efforts of the core Safety department by addressing increasing AE workloads, as well as performance increases through the application of new architectural and technology elements. Product Manager Kapil Kedia said, “The new enhancements in this release ensure that Argus users will continue to utilize the most advanced safety database available. Users will realize significant operational efficiencies through a set of unique features.”
Argus 4.2 SP2 also features enhancements to its risk management applications. Product Manager Muneet Burke, MD, commented, “Users will note performance improvements to Argus Insight™ and greater usability of Argus Perceptive™. Configuration enhancements and interactive alerting features will allow companies to more readily address post-marketing commitments to regulators.”
The Argus 4.2 SP2 upgrade ensures that Relsys stays in regulatory compliance and continues to offer the most advanced Safety & Risk Management system available.
Current Relsys clients may learn more about the Argus Safety™ Suite, including integrated risk management capabilities, at the upcoming Argus Safety User Group in Vancouver, Canada. Please contact your account representative for more information regarding this event.
About Relsys International
Relsys International provides the industry-leading Argus suite, a complete systems solution for pharmacovigilance and risk management that helps pharmaceutical, biotech and medical device companies improve drug safety and ensure ongoing compliance with global regulations. The company, founded in 1987, works in partnership with its customers to develop and deliver innovative solutions to long-term business needs, and to provide critical components to support its clients’ corporate risk management strategies. Argus Safety™, the company’s flagship product, is the world’s best selling adverse event reporting software, and is used by more of the leading pharmaceutical companies than any other solution. Relsys is a privately held company, headquartered in Irvine, California. For more information, visit www.relsys.net, or call +1 949-453-1715.
Back to News Headlines
|
|
